Foghorn Therapeutics Inc.
Biotechnology ResearchView the employees at
Foghorn Therapeutics Inc.-
Andrew Germain Vice President, Legal at Foghorn Therapeutics, Inc
-
Somerville, Massachusetts, United States
-
Top 10%
-
Overview
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.